Skip to main content
. 2024 Feb 29;14(3):148. doi: 10.3390/metabo14030148

Figure 4.

Figure 4

(A,B) ROC analyses of (A) Glycine/phosphatidylcholine (PC) ae C38:2 and (B) Putrescine/PC aa C32:0 ratios that segregate patients with the longest overall survival.